Inflammation in Tumorigenesis and Cancer Treatment, Volume 9
From Molecular Mechanisms to Personalized Therapeutic Strategies
- 1st Edition - August 29, 2026
- Latest edition
- Editors: Chunxiang Zhang, Mowei Kong
- Language: English
Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies explores the pivotal role of inflammation in cancer. It uncove… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Inflammation in Tumorigenesis and Cancer Treatment: From Molecular Mechanisms to Personalized Therapeutic Strategies explores the pivotal role of inflammation in cancer. It uncovers the molecular dialogue between inflammatory factors and tumor cells, illuminating pathways that drive oncogenesis and metastasis. Highlighting the rapid pace of discovery, the book bridges the gap by translating complex data into actionable clinical strategies, catering to students and professionals and addressing personalized medicine. Early chapters focus on the fundamental concepts of inflammation in cancer and recent advances in research, while also covering the impact of inflammatory mediators on signaling pathways and oncogenesis.
Other sections explore therapeutic strategies targeting inflammatory pathways and the role of immunometabolism and discuss biomarker discovery and personalized treatment plans. The final section examines the tumor microenvironment, the microbiome's role, and the intersection of immunotherapy and inflammation. The book offers numerous benefits to its audience. For scientists and researchers, it provides cutting-edge knowledge to inspire new research directions and foster interdisciplinary collaboration while serving as a valuable educational tool for the next generation of researchers.
Other sections explore therapeutic strategies targeting inflammatory pathways and the role of immunometabolism and discuss biomarker discovery and personalized treatment plans. The final section examines the tumor microenvironment, the microbiome's role, and the intersection of immunotherapy and inflammation. The book offers numerous benefits to its audience. For scientists and researchers, it provides cutting-edge knowledge to inspire new research directions and foster interdisciplinary collaboration while serving as a valuable educational tool for the next generation of researchers.
Key features
Key features
- Provides the latest insights into inflammation's role in cancer
- Presents an interdisciplinary, in-depth analysis that reveals the molecular mechanisms of inflammatory mediators in tumor development
- Drives new research directions, ideas, and innovative approaches
- Offers strategies for developing personalized treatment plans based on a patient’s unique inflammatory profile
- Enhances clinicians' ability to make informed decisions, improving patient outcomes with the latest therapeutic approaches
Readership
Readership
Researchers and clinicians in immuno-oncology and related fields
Table of contents
Table of contents
Section I: Foundational concepts
1. Introduction
Mowei Kong, Chunxiang Zhang
2. Emerging technologies and future research directions in inflammation and cancer research
Xingwei Zhao, Yang Yu
Section II: Micro/nano-modulation of cancer inflammation and immuno-metabolism
3. Recent advances and future research directions in the crosstalk between inflammation and tumors
Shuai Shao
4. Micro/nano-modulation of inflammatory signaling pathways in cancer
Xilong Wu, Yundi Wu, Cong Wang, Huanran Qu, Ruocan Liu
Section III: Translational research and therapeutic targets
5. Micro/nanoplatforms for modulating programmed cell death and tumor inflammation
Xilong Wu, Huanran Qu, Yundi Wu
6. Micro/nano-enabled immunometabolic regulation in inflammatory tumors
Xilong Wu, Ruocan Liu, Yundi Wu
Section IV: Biomarkers and personalized medicine
7. Biomarker discovery and validation in inflammatory cancer research
Xiangfeng Guan
8. Personalized medicine utilizing biomarkers
Jingsong Shen, Zheng Xie
Section V: Clinical implications and therapeutic strategies
9. Inflammation and tumor microenvironment
Meng Xia
10. Antineoplastic potential of nonsteroidal antiinflammatory drugs
Arkadiusz Surażyński, Magda Chalecka, Jerzy Palka
11. Immunotherapy and inflammation management
Yuyu Xie, Mowei Kong, Junfeng Yu
1. Introduction
Mowei Kong, Chunxiang Zhang
2. Emerging technologies and future research directions in inflammation and cancer research
Xingwei Zhao, Yang Yu
Section II: Micro/nano-modulation of cancer inflammation and immuno-metabolism
3. Recent advances and future research directions in the crosstalk between inflammation and tumors
Shuai Shao
4. Micro/nano-modulation of inflammatory signaling pathways in cancer
Xilong Wu, Yundi Wu, Cong Wang, Huanran Qu, Ruocan Liu
Section III: Translational research and therapeutic targets
5. Micro/nanoplatforms for modulating programmed cell death and tumor inflammation
Xilong Wu, Huanran Qu, Yundi Wu
6. Micro/nano-enabled immunometabolic regulation in inflammatory tumors
Xilong Wu, Ruocan Liu, Yundi Wu
Section IV: Biomarkers and personalized medicine
7. Biomarker discovery and validation in inflammatory cancer research
Xiangfeng Guan
8. Personalized medicine utilizing biomarkers
Jingsong Shen, Zheng Xie
Section V: Clinical implications and therapeutic strategies
9. Inflammation and tumor microenvironment
Meng Xia
10. Antineoplastic potential of nonsteroidal antiinflammatory drugs
Arkadiusz Surażyński, Magda Chalecka, Jerzy Palka
11. Immunotherapy and inflammation management
Yuyu Xie, Mowei Kong, Junfeng Yu
Product details
Product details
- Edition: 1
- Latest edition
- Published: August 29, 2026
- Language: English
About the editors
About the editors
CZ
Chunxiang Zhang
Dr. Chunxiang Zhang is a distinguished cardiologist and academic leader with extensive international experience in cardiology and oncology. He holds a Doctor of Cardiology degree and completed his postdoctoral fellowship in cardiovascular pharmacology in the US. Currently serving as the Deputy Secretary of the Party Committee and President of Southwest Medical University, he also directs the Key Laboratory of the Ministry of Education. His career spans over three decades, including ten years in top cardiology departments in China and 22 years in the US, where he held prestigious positions at the University of Tennessee and Rush University. Dr. Zhang's research delves into the molecular mechanisms of tumorigenesis, inflammation, and cancer therapies, with notable work on tetraspanins in digestive system cancers and innovative therapeutic strategies. His comprehensive research and publications provide valuable insights into signaling pathways, biomarkers, and clinical implications, making him a key figure in advancing cancer treatment and understanding.
Affiliations and expertise
Deputy Secretary of the Party Committee and President of Southwest Medical University; Director of the Key Laboratory of the Ministry of Education, ChinaMK
Mowei Kong
Dr. Mowei Kong, MD, is a seasoned medical professional with a rich background in endocrinology, metabolism, oncology, and cardiovascular diseases. He previously served as a clinical physician at Guiqian International Hospital and is currently engaged in basic research at Southwest Medical College. Dr. Kong's expertise spans Type 2 Diabetes, insulin resistance, obesity, gastrointestinal and cardiac tumors, and coronary heart disease. Some notable works include studies on CTRP6's role in digestive system tumors and GLP-1 receptor agonists' effects on lipotoxicity.
His experience in these areas highlights his ability to analyze signal transduction pathways, identify new therapeutic targets, and translate basic scientific research into clinical applications. Dr. Kong's comprehensive experience in both clinical practice and research enables him to provide valuable insights and advancements in the understanding and treatment of cancer and related conditions.
Affiliations and expertise
Researcher, Southwest Medical College, ChinaView book on ScienceDirect
View book on ScienceDirect
Read Inflammation in Tumorigenesis and Cancer Treatment, Volume 9 on ScienceDirect